WB results showed that the SREBF1-related lipid metabolism axis was significantly suppressed in HCC cells subjected to combined RG3 and CTD treatment, whereas PRMT1 overexpression notably attenuated this suppressive effect (Fig. 5F, G). This evidence concerns the gene PRMT1 and hepatocellular carcinoma.